Issue

Vol. 66 No. 6: Issue 6

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Significance changes in the levels of myocardial enzyme in the child patients with Mycoplasma Pneumoniae Pneumonia

https://doi.org/10.14715/cmb/2020.66.6.8
Xueliang Qi
Department of paediatrics，Linyi central hospital of Shandong province，Linyi，276400，Shandong，China.
Xiangguo Sun
Department of paediatrics，Linyi central hospital of Shandong province，Linyi，276400，Shandong，China.
Xuemin Li
Department of paediatrics，Linyi central hospital of Shandong province，Linyi，276400，Shandong，China.
Dejin Kong
Department of paediatrics，Linyi central hospital of Shandong province，Linyi，276400，Shandong，China.
Luhua Zhao
Department of paediatrics，Linyi central hospital of Shandong province，Linyi，276400，Shandong，China.

Corresponding Author(s) : Luhua Zhao

15253920120@163.com

Cellular and Molecular Biology, Vol. 66 No. 6: Issue 6

Abstract

Mycoplasma is a gram-negative with thin wall bacterium that in humans, Mycoplasma pneumoniae causes pneumonia. This experiment was designed to explore the changes of myocardial enzymes in the mycoplasma pneumoniae pneumonia (MPP) child patients, and analyze the clinical value of these changes, in combination with the relevant indicators, symptoms and signs, in the evaluation of the pneumonia mycoplasma infection. For this aim, a total of 120 child patients with MPP in the acute phase,120 child patients with MPP in the recovery phase and 120 healthy children were simultaneously enrolled into this study to detect the levels of aspartate aminotransferase (AST), creatine kinase (CK), Creatine Kinase Isoenzyme (CK-MB) and lactic dehydrogenase (LDH) in blood. Results showed that MPP patients in the acute phase had higher levels of LDH, CK, CK-MB, AST, PCt, CRP, MPV, PDW, PCt, percentage of neutrophils, WBC count in the peripheral blood and ESR than those of the patients in the recovery patients and healthy children, while the level of PLT was lower (all P<0.05). In the acute phase, the level of CK-MB correlated to the fever, fever duration, extrapulmonary organ damage (except for the myocardial damage) and the antibody titer of MP (all P<0.05). It was concluded that in the acute phase of MMP, the level of CK-MB could not only reflect the myocardial damage readily but also the infection of MP as well as the resultant inflammation and disease progression, which could effectively guide the diagnosis and treatment of MPP.

Keywords

Mycoplasma pneumoniae Mycoplasma pneumoniae pneumonia Myocardial enzymes Myocardial damage.
Qi, X., Sun, X., Li, X., Kong, D., & Zhao, L. (2020). Significance changes in the levels of myocardial enzyme in the child patients with Mycoplasma Pneumoniae Pneumonia. Cellular and Molecular Biology, 66(6), 41–45. https://doi.org/10.14715/cmb/2020.66.6.8
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004; 17: 697–728.
  2. Talkington DF, Waites KB, Schwartz SB Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis, and epidemiology of human Mycoplasma pneumoniae infections. In: Scheld, WM, Craig, WA, Hughes, JM (eds). Emerging infections 5, Washington, DC: American Society for Microbiology, 2001; pp. 57–84.
  3. Meseguer MA, Pérez-Molina JA, Fernández-Bustamante J. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr Infect Dis J 1996; 15: 829–831.
  4. Hu YM, Jiang ZF, Zhu FT. Practical pediatrics, 7th edn. Beijing: People's Medical Publishing House, 2002.
  5. Youn YS, Lee KY, Hwang JY. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010; 10: 48–48.
  6. Foy, HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17(suppl 1): S37–S46.
  7. Ursi D, Ursi JP, Ieven M. Congenital pneumonia due to Mycoplasma pneumoniae. Arch Dis Child Fetal Neonatal Ed 1995; 72: F118–F120.
  8. Kumar S, Maria A, Saigal, SR. Mycoplasma pneumoniae as a cause of non-resolving pneumonia in a neonate. J Med Microbiol 2010; 59: 731–732.
  9. Hawkins, S, Rausch, CM, McCanta, AC. Constrictive pericarditis secondary to infection with Mycoplasma pneumoniae. Curr Opin Pediatr 2011; 23: 126–129.
  10. Nagashima M, Higaki T, Satoh H. Cardiac thrombus associated with Mycoplasma pneumoniae infection. Interact Cardiovasc Thorac Surg 2010; 11: 849–851.
  11. Barski L, Nevzorov R, Horowitz J. Antibodies to various mycoplasmas in patients with coronary heart disease. Isr Med Assoc J 2010; 12: 396–399.
  12. Nagashima M, Higaki T, Satoh H. Cardiac thrombus associated with Mycoplasma pneumoniae infection. Interact Cardiovasc Thorac Surg 2010; 11: 849–851.
  13. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 2010; 16: 162–169.
  14. Yang, J, Hooper, WC, Phillips, DJ. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 2004; 15: 157–168.
  15. Klein G, Berger A, Bertholf R, et al. Multicenter evaluation of liquid reagents for CK, CK-MB and LDH with determination of reference intervals on Hitachi Systems. Clin Chem 2001; 47: Suppl A30.
  16. Thomas L, Müller M, Schumann G. Consensus of DGKL and VDGH for interim reference intervals on enzymes in serum. J Lab Med 2005; 29: 301–308.
  17. Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 2012; 55: 42–47.
  18. Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health 2005; 41: 671–676.
  19. Defilippi A, Silvestri M, Tacchella A. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008; 102: 1762–1768.
  20. Zhang L. Clinical analysis of the pathogenesis of mycoplasma pneumonia in children. Di Yi Jun Yi Da Xue Xue Bao 2005; 25: 1574–1576.
  21. Gorina LG, Goncharova SA, Rakovskaia IV. Detection of mycoplasma antigens and immune complexes in sera of the children with bronchial asthma. Zh Mikrobiol Epidemiol Immunobiol 2006; 4: 85–88.
  22. Mo W-G, Huang Z, Yang G-L. Developmental changes and clinical significance of immunological function in the cases with Mycoplasma pneumoniae pneumonia. Chinese J Maternal Child Health Care 2006; 21: 3437–3438.
  23. Sheikhvatan M, Boroumand MA, Behmanesh M, Ziaee S, Cheraghee S. Integrin Beta-3 Gene Polymorphism and Risk for Myocardial Infarction in Premature Coronary Disease. Iran J Biotechnol. 2019; 17(2): e1921.
  24. Chittoor JT, Balaji L, Jayaraman G. Optimization of Parameters that Affect the Activity of the Alkaline Protease from Halotolerant Bacterium, Bacillus acquimaris VITP4, by the Application of Response Surface Methodology and Evaluation of the Storage Stability of the Enzyme. Iran J Biotechnol. 2016; 14(1): 23-32.
  25. Mohammadi S, Nikkhah M. TiO2 Nanoparticles as Potential Promoting Agents of Fibrillation of α-Synuclein, a Parkinson's Disease-Related Protein. Iran J Biotechnol. 2017; 15(2): 87-94.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 862 Download : 509